Gene therapy for hemophilia has emerged as a revolutionary treatment option that could change the lives of those managing this bleeding disorder.For patients like Terence Blue, who became the first recipient of Hemgenix for hemophilia B in New England, this therapy offers a glimmer of hope by potentially eliminating the need for constant injections of clotting factors.